Insulin Aspart Dosage
Links shared publicly online about this topic
NOVOLOG MIX 70/30 (Insulin aspart, Insulin aspart protamine) drug information from MPR
empr.com — “NOVOLOG MIX 70/30 (Insulin aspart, Insulin aspart protamine) drug information for Diabetes mellitus~hyperglycemic agents from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on February 14, 2011 at 5:06 am By:
MPR News: NOVOLOG MIX 70/30: Adults: changed peak to 2.4 hours. Warnings/Precautions: Pregnancy (Cat.B). http://bit.ly/hOQvFA
Use of short-acting insulin aspart in managing older people with diabe
dovepress.com — “Use of short-acting insulin aspart in managing older people with diabetes eltayeb marouf, alan j sinclairinstitute of diabetes for older people – idop, bedfordshire and hertfordshire postgraduate medical school, university of bedfordshire, ukabstract: type 2 diabetes mellitus affects 5.9% of the world adult population, with older people and some ethnic groups disproportionately affected. treatment of older people with diabetes differs in many ways from that in younger adults since the majo” View full resource at dovepress.com
Most Recently Shared on April 20, 2009 at 7:08 pm By:
Use of short-acting insulin aspart in managing older people with diabetes - http://tinyurl.com/ce2p44
Insulin Aspart by Jet Injection Enhances Absorption - QualityPoint Technologies
qualitypointtech.net — “The study, the first to compare jet injection with insulin pen devices, found that jet injection took half as long as pen devices to reach maximal glucose-lowering effect. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on July 10, 2011 at 6:00 am By:
Insulin Aspart by Jet Injection Enhances Absorption: The study, the first to compare jet injection with insulin pe... http://bit.ly/pSUG8V
Insulin Glulisine Compared to Insulin Aspart and t... [Diabetes Technol Ther. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on April 7, 2011 at 3:45 am By:
Insulin Glulisine Compared to Aspart & Lispro Administered by CSII in Patients with Type 1 #Diabetes: RCT http://1.usa.gov/fX2sLy #hypoglyc
Study Finds Visually Impaired People Get Insulin Pen Dosages Right
medicalnewstoday.com — “Labels on the popular insulin pen used by people with diabetes warn against visually-impaired people using pens to measure out and administer their insulin dosage.A Case Western Reserve” View full resource at medicalnewstoday.com
Most Recently Shared on July 3, 2010 at 12:04 pm By:
Study Finds Visually Impaired People Get Insulin Pen Dosages Right http://mnt.to/3FH8 #eyehealth
Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart With RHuPH20 In Type 1 And Type 2 Diabetes
medicalnewstoday.com — “Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the” View full resource at medicalnewstoday.com
Most Recently Shared on September 3, 2010 at 1:12 pm By:
Scott Strumello Patient Expert
RT @mnt_diabetes Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart Wi.. http://bit.ly/arqKXo
MedWire News - Diabetes - Insulin degludec/aspart mix shows promise in phase II trial
medwire-news.md — “MedWire News A new insulin coformulation, known as IDegAsp, has shown initial promise in a proof-of-concept trial when given once daily in combination with metformin to patients with Type 2 diabetes. MedWire News” View full resource at medwire-news.md
Most Recently Shared on March 18, 2011 at 12:56 pm By:
Insulin degludec/aspart mix shows promise in phase II trial http://bit.ly/i1hncJ #diabetes
Mixing Insulin Aspart With Detemir Does Not Affect Glucose Excursion In Children With Type 1 Diabetes Mellitus " Diabetes Care
care.diabetesjournals.org — “Mixing Insulin Aspart With Detemir Does Not Affect Glucose Excursion In Children With Type 1 Diabetes Mellitus " Diabetes Care” View full resource at care.diabetesjournals.org
Most Recently Shared on June 4, 2010 at 8:46 pm By:
Mixing #Insulin Aspart With Detemir Does Not Affect Glucose Excursion In Children With Type 1 #Diabetes Mellitus http://bit.ly/bkC3Wn
NYTimes: Insulin Study Could Lead to New Dosage Devices - Personal Medicine
personalmedicine.posterous.com — “NYTimes: Insulin Study Could Lead to New Dosage Devices - Personal Medicine” View full resource at personalmedicine.posterous.com
Most Recently Shared on February 5, 2010 at 3:16 am By:
Personal Medicine in Paducah, Kentucky. Dr Hodge was a featured speaker at the Mayo Clinic's Transform Symposium
in '09 and has been named by Brian Dolan of Mobi Heath News as "The
First iPhone Doctor". She is the author of The Personal Pediatrics Primer for the Progressive Parent.
Dr. Hodge's special interests in pediatrics include nutrition,
prevention and the potential for the internet to strengthen physician
patient relationships. Dr. Hodge is a member of the Health care
Information and Management Systems Society (HIMSS), a Fellow of the
Academy of Pediatrics' Quality and Innovation Network, and a founding
member of the Society for Participatory Medicine. Participatory Medicine
is an emerging group of engaged patients and physicians who believe
that mutual trust and understanding as well as use of media, health IT strengthens the physician patient relationship and provides for better care." /> Natalie Hodge, MD, FAAP Pediatrician, Physician, Active Health Library, and Doctor
NYTimes: Insulin Study Could Lead to New Dosage Devices http://post.ly/MFbV
Insulin Study Could Lead to New Dosage Devices - NYTimes.com
nytimes.com — “A new study points toward a different way of regulating children’s glucose levels by using a continuous glucose monitor instead of the standard diabetes management system.” View full resource at nytimes.com
Most Recently Shared on February 5, 2010 at 7:23 am By:
Insulin Study Could Lead to New Dosage Devices (via @nytimes): http://nyti.ms/awf1Dc
Insulin Study Could Lead to New Dosage Devices - NYTimes.com
nytimes.com — “A new study points toward a different way of regulating children’s glucose levels by using a continuous glucose monitor instead of the standard diabetes management system.” View full resource at nytimes.com
Most Recently Shared on February 5, 2010 at 2:48 am By:
Insulin Study Could Lead to New Dosage Devices http://nyti.ms/9O77cP
Insulin Study Could Lead to New Dosage Devices - NYTimes.com
nytimes.com — “A new study points toward a different way of regulating children’s glucose levels by using a continuous glucose monitor instead of the standard diabetes management system.” View full resource at nytimes.com
Most Recently Shared on February 7, 2010 at 5:29 pm By:
Helen Hilts, MD Active Health Library, Doctor, Family Medicine Doctor, and Physician
NY Times's take on developing an 'artificial pancreas' http://nyti.ms/9PSWvO. Maybe someday soon!
Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes — Diabetes Care
instapaper.com — “Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes — Diabetes Care” View full resource at instapaper.com
Most Recently Shared on February 23, 2011 at 12:07 pm By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Exenatide is noninferior to insulin for glycemic control but superior for hypoglycemia and weight control: http://bit.ly/fddwvT
Effects of Mealtime Insulin Aspart and Bedtime NPH Insulin on Postprandial Inflammation and Endothelial Cell Function in Patients with Type 2 Diabetes - Bladbjerg - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
onlinelibrary.wiley.com — “Effects of Mealtime Insulin Aspart and Bedtime NPH Insulin on Postprandial Inflammation and Endothelial Cell Function in Patients with Type 2 Diabetes - Bladbjerg - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on April 24, 2011 at 1:21 pm By:
Effects of Mealtime Insulin Aspart and Bedtime NPH Insulin on Postprandial Inflammation and… http://goo.gl/fb/PQYEP
Effects of Mealtime Insulin Aspart and Bedtime NPH Insulin on Postprandial Inflammation and Endothelial Cell Function in Patients with Type 2 Diabetes - Bladbjerg - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
onlinelibrary.wiley.com — “Effects of Mealtime Insulin Aspart and Bedtime NPH Insulin on Postprandial Inflammation and Endothelial Cell Function in Patients with Type 2 Diabetes - Bladbjerg - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on April 23, 2011 at 6:47 pm By:
Endocrinology Wisdom OW Health
Effects of Mealtime Insulin Aspart and Bedtime NPH Insulin on Postprandial Inflammation and Endothelial Cell Fun... http://bit.ly/gMcxGw
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Jim
Editor of Glycosmedia
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
Advertisement
